Literature DB >> 3920518

Treatment of hyponatremia.

R W Schrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3920518     DOI： 10.1056/NEJM198504253121709

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Hypoalbuminaemic hyponatraemia: a new syndrome?

Authors:  P Dandona; V Fonseca; D N Baron
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-02

2.  Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin.

Authors:  F A László; C Varga; T Dóczi
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 3.  Current Challenges in the Evaluation and Management of Hyponatremia.

Authors:  Kerri McGreal; Pooja Budhiraja; Nishank Jain; Alan S L Yu
Journal:  Kidney Dis (Basel)       Date:  2016-05-14

4.  Lack of efficacy of phenytoin in the syndrome of inappropriate anti-diuretic hormone secretion of neurological origin.

Authors:  G Decaux; S Przedborski; A Soupart
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 5.  Chronic fatigue syndrome. A critical appraisal of the role of Epstein-Barr virus.

Authors:  D Koo
Journal:  West J Med       Date:  1989-05

6.  Inappropriate secretion of antidiuretic hormone, polydipsia and hypothalamic calcifications.

Authors:  P Gross; A Wichmann; D Walb; J Hensen; S Abdelhamid
Journal:  Klin Wochenschr       Date:  1989-07-17

Review 7.  Efficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-Analysis.

Authors:  Xiangyun Zhang; Mingyi Zhao; Wei Du; Dongni Zu; Yingwei Sun; Rongwu Xiang; Jingyu Yang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.